Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Insurance coverage details are verified with your specific plan, as policies vary significantly
Methods: The current placebo-controlled double-blind randomized clinical trial was performed on 46 women with obesity, randomly allocated to either concomitant supplementation [L-carnitine tartrate (2 500 mg/day) + multistrain/multispecies synbiotic (1 capsule/day)] or monotherapy [L-carnitine tartrate (2 500 mg/day) + maltodextrin (1 capsule/day)] groups for 8 weeks
To report suspected severe side effects or adverse reactions to compounded trizepatide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
Lancet (2021) 397(10278):97184
At the treatment endpoint of 176 weeks, 99% of prediabetic patients were still diabetes-free
US$ 28.20
US$ 28.21
US$ 29.59
